Compare CC & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CC | HTFL |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2014 | N/A |
| Metric | CC | HTFL |
|---|---|---|
| Price | $17.85 | $20.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $18.44 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 3.4M | 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,638,000,000.00 | N/A |
| Revenue This Year | $5.80 | $40.42 |
| Revenue Next Year | $5.58 | $22.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $9.13 | $20.13 |
| 52 Week High | $21.85 | $41.22 |
| Indicator | CC | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 35.26 |
| Support Level | $14.33 | $20.13 |
| Resistance Level | $18.09 | $25.05 |
| Average True Range (ATR) | 1.05 | 1.41 |
| MACD | -0.14 | -0.05 |
| Stochastic Oscillator | 73.98 | 5.23 |
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.